|
HS Code |
292496 |
| Name | Closantel EP/CPV |
| Appearance | White to pale yellow crystalline powder |
| Chemical Formula | C22H14Cl2I2N2O2 |
| Molecular Weight | 663.08 g/mol |
| Cas Number | 57808-65-8 |
| Pharmacological Class | Anthelmintic |
| Solubility | Practically insoluble in water, soluble in dimethylformamide |
| Storage Conditions | Store in a cool, dry place away from light |
| Melting Point | 212-214°C |
| Usage | Used in veterinary medicine to treat parasitic worm infections |
| Route Of Administration | Oral or injectable (veterinary use only) |
As an accredited Closantel EP/CPV factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Closantel EP/CPV is packaged in a 1 kg sealed, high-density polyethylene container with a tamper-evident cap and clear labeling. |
| Shipping | Closantel EP/CPV should be shipped in tightly sealed, clearly labeled containers, protected from light and moisture. Transport under ambient temperatures, avoiding extreme heat. Handle in accordance with local regulations for hazardous chemicals. Ensure safety data sheets accompany the shipment for proper handling and emergency measures during transit. |
| Storage | Closantel EP/CPV should be stored in a tightly closed container, protected from light and moisture. Keep it in a cool, dry place at a temperature not exceeding 25°C. Store away from incompatible substances, such as strong oxidizers, and ensure proper ventilation. Keep out of reach of children and unauthorized personnel. Adhere to relevant pharmaceutical and chemical storage regulations. |
Competitive Closantel EP/CPV prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Growing up around livestock, you get to see firsthand how parasites can wreck an entire operation. I remember the frustration, the hours spent chasing some fleeting solution that made promises but always fell short in daily use. In all those seasons, I realized a dependable product means more than just a chemical on paper—it means seeing healthier herds, better yields, and fewer setbacks. That’s where Closantel EP/CPV comes into the conversation, changing the daily grind of keeping animals healthy.
Closantel EP/CPV stands out because it’s not just another formula in a long line of anthelmintics. The ingredient itself, Closantel, was recognized by veterinarians for its broad activity against blood-sucking parasites that cripple ruminants. What stood out to me is the way this product addresses liver flukes, Haemonchus, and other tough-to-treat pests that keep herders up at night. The two grades—EP (European Pharmacopoeia) and CPV—get their names from stringent standards defining purity and manufacturing controls. EP matches the requirements seen across the EU, which tells you this product comes with expectations for both quality and traceability. The CPV grade, favored in many national programs, commits to consistent composition so animals receive the same protection season after season.
Everyone who’s been around veterinary products knows it isn’t just about having a strong molecule, it’s about the precise balance and purity. Closantel EP/CPV gives a clear yellow to brown crystalline powder, a physical form that mixes efficiently into feed and water-based treatments. This powder avoids the sticky problems of overdosing or unpredictable release rates. It’s odorless, which makes a real difference because livestock shy away from anything unfamiliar in their feed bin.
A big deal with this product is particle size—most granules fall within a tight range, meeting direct mixing needs without clumping. This comes from years of manufacturing tweaks that put farm usability first. The producers claim purity above 98% by HPLC, supported by public batch analysis, showing that this powder delivers as much Closantel as the label says. This kind of verification matters on practical ranches. You see a difference in dosing protocols—less guesswork, fewer repeat treatments, clearer compliance with animal welfare commitments.
You can judge a product by its shelf life and storage demands. Closantel EP/CPV holds up under standard storage for over two years without detectable loss in potency. In the field, where cool rooms aren’t an option, this consistency turns into real savings because spoiled drugs cost time and animal lives.
Farmers and technicians talk about the pain of dosing hundreds of head, needing to make every gram of product count. Closantel EP/CPV finds its role in both professional formulations and on-farm custom mixtures. It dissolves in common carrier solutions, which allows use in injectable preparations and oral drenches. This versatility means herds get the same treatment whether you run a high-end CLINIC or a backyard goat pen.
I think back to one winter with parasite outbreaks across all our sheep paddocks. Every old-timer tried a favorite remedy. Only the product containing Closantel cut through persistent infestations. Reports from several EU member states and published trials echo this with evidence of lower resistance buildup compared with alternatives like ivermectin. It’s not about chasing higher doses, but about making each dose count with minimal retreatment—something producers push for to protect both the herd and the bottom line.
Resistance is everybody’s nightmare. Closantel EP/CPV helps manage that risk through its specific action on oxidative phosphorylation in the target parasite, which is different from macrocyclic lactones and benzimidazoles. By mixing and rotating actives, veterinarians slow down the inevitable march of resistance. This approach keeps animals productive and safeguards future tools by not leaning on any single formula for too long.
Dosing protocols with this product have received broad veterinary endorsements. The typical payout: a lower worm burden across treated pens, with follow-up egg counts confirming real drops in transmission. In countries monitoring Closantel output, post-market surveillance identified fewer cases of underdosing or overdosing—practical signs that clear instructions and trusted powder characteristics lead to safer food supply and more predictable cost planning.
After watching dozens of products try to carve out their space, I can say Closantel brings critical differences to the table—and so does the way EP/CPV is manufactured and checked. Compared to older treatments like levamisole or modern macrocyclic standbys such as doramectin, Closantel targets a unique set of parasites at different life stages. It isn’t about chasing symptoms. Instead, Closantel interrupts the energy cycle of susceptible worms, which shows up not only in blood work but also in healthier coats, improved appetite, and weight gain in post-treatment records.
Many common anthelmintics struggle in resistance hotspots. The responsible use of Closantel, guided by periodic vet assessments, has kept it viable over decades. Scientific literature and meta-analyses back this up with published cure rates above 90% for the toughest bloodsuckers in sheep, goats, and cattle. When you have publicly available resistance mapping, Closantel consistently shows fewer hot spots than off-patent predecessors, especially in mixed-grazing systems.
Some folks ask about withdrawal times and market access. Closantel EP/CPV matches compliance needs for food animals across regulated markets by maintaining residue levels well below set limits when used as directed. This alignment matters because producers won’t risk their license over uncertainty; they want products that leave no question of safety for milk or meat.
Budget also shapes every rancher’s choices. On a per-dose basis, Closantel compares favorably to imported macrocyclics, especially when considering extended protection intervals. The benefit adds up when you calculate fewer vet visits, reduced stress on herds, and less labor rehandling animals. These details translate off the balance sheet into real-world quality of life for both livestock and handlers, taking some unpredictability out of animal health management.
Experience on a working farm teaches you that every bottle and every bag matters. People worry over adulteration, subpotency, and inconsistent performance. These concerns come not just from headline scandals but from routine disappointments that erode faith in your whole health plan. Closantel EP/CPV is made under documented controls, using active ingredient traceability through batch records. Samples from each run undergo independent verification using reference standards, so unexpected batches rarely slip by unnoticed—this is a relief to producers required by law or trade contracts to document every treatment down to lot number.
Veterinary training focuses as much on paperwork as on biology. The lot consistency and clear traceability records mean compliance audits become less painful. Regulators from France to Australia regularly cross-check batch numbers, allowing for quick traceback if any concern arises. No one wants to deal with recalls, but the controls behind this product minimize that risk by anticipating problems long before they reach the user.
I can think of conversations with field techs who value this paper trail—knowing they can contact a manufacturer or distributor, point to a lot number, and get answers rather than excuses. This relationship of transparency supports trust not just between humans but also, indirectly, the welfare of the animals in their care.
Any discussion about a veterinary drug starts with the animals but stretches out to the people who handle it—and the ground they stand on. Closantel EP/CPV comes with real-world handling guidelines supported by both regulatory agency reviews and new independent research. What stood out to me in the documentation was the clear advice on avoiding accidental ingestion or inhalation—not every product gets so practical with its labels, but on busy farms, these details save time and prevent accidents, especially among younger hands learning on the job.
You rarely see language drift from lab into layman’s terms, but safety with Closantel keeps to a straightforward message: weigh out accurate doses, use gloves, and keep mixing stations tidy. These habits show up in lower numbers of adverse reactions reported to farm safety bodies and local clinics.
Environmental impact also comes to the fore with every new regulatory wave. Unlike many organophosphates from decades past, Closantel has a low volatility and limited off-field movement after land application. Proper manure management and responsible dosing lower the chance for waterway contamination, according to recent environmental monitoring studies. Careful stewardship keeps the chemical footprint manageable—a big win for operations locked in by increasing environmental scrutiny.
Residues entering the food chain lead to the most public worry and regulatory action. Routine residue screens at national labs, published in food safety reports, continue to show that Closantel-based treatments clear from edible tissues within labeled intervals. This helps keep local and export markets open, protecting farmer revenue and public health.
What matters in daily farm life is knowing animals thrive with as little intervention as possible. Better parasite control keeps the flock or herd healthy without endless cycles of retreatment or strengthened chemical cocktails. Closantel EP/CPV allows targeted, effective care that respects this principle. Healthy animals use feed better, grow faster, and cost less to manage. You notice it in steadier supply chains and more predictable outputs.
Anyone who has walked pens day after day with sick or stunted animals understands the stress this places on everyone involved. A reliable, consistent product takes pressure off owners and staff, knits some peace of mind back into the routine. By reducing uncertainty, Closantel EP/CPV supports both animal welfare and farm economics.
For those raising animals for show, breeding, or commercial production, competitive edge can hinge on fine details. Having a product you trust, backed by regulators, international trade partners, and local practitioners, tips the outcome in your favor. My own experience echoes what colleagues say—you build a good reputation with healthy livestock, not just with strong marketing or paperwork.
Parasite control owes much of its progress to honest assessment of what works and what doesn’t. Closantel EP/CPV represents an answer to some of the toughest questions, but it’s not a silver bullet. Resistance cycles through the countryside in waves and will eventually challenge every molecule in use. Anyone who ignores this ends up chasing the problem with increasingly desperate fixes.
Real-world solutions start by integrating Closantel as part of a broader management plan: regular egg counts, pasture rotation, and targeted treatment campaigns. The data from veterinary authorities suggest that farms rotating Closantel with unrelated actives hold parasite numbers lower for longer, with fewer resistance alarms. This practice allows for smarter spending and a more sustainable system.
Veterinarians rely on solid surveillance—fecal egg counts before and after dosing, periodic review of withdrawal intervals, and feedback on dosing compliance. These steps make sure the powder delivers on its promise, and weak lots or improper dosing get flagged early. Training for handlers, clear labelling, and practical on-farm demonstrations all help get the most from each batch ordered.
Communication with product representatives, especially in the case of new outbreaks or unexpected side effects, leads to ongoing improvement of both the powder and the education around its use. Working together this way, practitioners and producers steer the future of animal health in a direction that puts welfare and safety ahead of old habits and shortcuts.
Research into parasite biology and resistance is picking up speed as demand for protein rises globally. Scientific groups dedicate more resources to long-term monitoring—mapping resistance gene frequencies and tracing them farm by farm. Closantel EP/CPV benefits from these efforts because it continues to receive up-to-date recommendations and revisions based on new field evidence, not just on legacy approvals.
Ongoing development focuses on delivery and compliance—improved formulations for ease of dosing, longer intervals between treatments, even the promise of combination products where Closantel pairs with synergists to keep the edge sharp against mixed parasite loads. The manufacturers backing EP/CPV run studies open to peer review, drawing on international collaboration, which lines up with regulatory, ethical, and food safety best practices.
As a working hand or a producer, you gain from this openness. The product today reflects not just old chemistry but current thinking and customer feedback, which goes far to keep Closantel EP/CPV at the front of the field.
Beyond chemistry and quality controls, it’s the relationship between people, animals, and management practices that shapes real success. Closantel EP/CPV supports this bond through clear information and consistent results. Herd managers notice the difference in productivity and reduced symptom days, while veterinarians appreciate drugs that make their job more predictable and rewarding.
Feedback from farm to lab keeps the product relevant. Today’s market values transparency, adherence to regulation, and careful stewardship as much as it does raw performance. By making each of these pillars part of the package, Closantel EP/CPV serves as a partner in achieving better animal health across many sectors of livestock production.
Every season brings a new set of challenges, and while there may never be a perfect solution, products developed with genuine feedback and proven science bridge the gap. Whether on a small family operation or a major commercial holding, the presence of Closantel EP/CPV offers assurance that solutions born of experience and evidence continue to guide the next chapter of veterinary medicine.